Suppr超能文献

使用3D打印成人鼻腔对气溶胶沉积进行可视化和定量评估。

Visualization and quantitative evaluation of aerosol deposition using 3D-printed adult nose cavities.

作者信息

He Wei, Shi Muhan, Lu Yaozhong, Chu Chengsheng, Wang Xiaolong, Wang Min, Zhang Xiaofang

机构信息

Breath Medical Co., Ltd., Hefei, PR China.

Department of Otorhinolaryngology, Head and Neck Surgery, Peking University People's Hospital, Xi Zhi Men Nan Da Jie 11#, Beijing, 100044, PR China.

出版信息

Heliyon. 2024 Sep 19;10(21):e38179. doi: 10.1016/j.heliyon.2024.e38179. eCollection 2024 Nov 15.

Abstract

Local steroid medication is one of the most important treatment options for chronic rhinosinusitis. Regional deposition has a higher clinical value compared with total deposition in predicting treatment outcomes or evaluating adverse reactions. The goal of this project is to propose an effective technique for visualizing and quantifying aerosol deposition in a three-dimensional adult nasal cavity, and to verify the practicality of this method. Three-dimensional (3D) nasal cavity models were constructed from computed tomography (CT) scans of one post-operative rhinosinusitis subject using imaging software. The nasal cast was coated with a water-indicating paste and deposited with saline; a liquid dressing was added to visualize the progress. The quantity of liquid dressing was evaluated via HPLC and the liquid deposition was analyzed within the nasal cast cavity. Herein, 98.77 % of the particles generated by the nebulizer were over 5 μm, suggesting that most of the aerosol could effectively enter the nasal cavity instead of the lower respiratory system. The liquid dressing was mainly deposited in the nasal cavity, ethmoid sinus, and frontal sinus according to the visualization tests. HPLC results suggested that the main deposits were the frontal sinus (up to 41.80 %) as well as in the sphenoid sinus and ethmoid sinus (14.00 %). The large particle nebulizer (BM-TCA) generally led to better deposition in sinus areas when compared to the smaller particle nebulizer (PARI). This technology allows for in vitro testing of various types of nasal preparations and equipment under various test methods.

摘要

局部用类固醇药物是慢性鼻-鼻窦炎最重要的治疗选择之一。与总沉积相比,区域沉积在预测治疗效果或评估不良反应方面具有更高的临床价值。本项目的目标是提出一种有效的技术,用于可视化和量化三维成人鼻腔中的气溶胶沉积,并验证该方法的实用性。使用成像软件,根据一名鼻-鼻窦炎术后患者的计算机断层扫描(CT)构建三维(3D)鼻腔模型。将鼻模涂上示水膏并注入盐水;添加液体敷料以观察进展情况。通过高效液相色谱法(HPLC)评估液体敷料的量,并在鼻模腔内分析液体沉积情况。在此,雾化器产生的颗粒中98.77%大于5μm,这表明大多数气溶胶可有效进入鼻腔而非下呼吸道。可视化测试显示,液体敷料主要沉积在鼻腔、筛窦和额窦。HPLC结果表明,主要沉积部位是额窦(高达41.80%)以及蝶窦和筛窦(14.00%)。与较小颗粒雾化器(PARI)相比,大颗粒雾化器(BM-TCA)通常在窦区有更好的沉积效果。该技术允许在各种测试方法下对各种类型的鼻腔制剂和设备进行体外测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9ba/11550752/aba5a6b50443/gr1.jpg

相似文献

1
Visualization and quantitative evaluation of aerosol deposition using 3D-printed adult nose cavities.
Heliyon. 2024 Sep 19;10(21):e38179. doi: 10.1016/j.heliyon.2024.e38179. eCollection 2024 Nov 15.
2
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
3
Assessing sinus aerosol deposition: benefits of SPECT-CT imaging.
Int J Pharm. 2014 Feb 28;462(1-2):135-41. doi: 10.1016/j.ijpharm.2013.12.032. Epub 2013 Dec 26.
7
Assessing volume growth of paranasal sinuses and nasal cavity in children using three-dimensional imaging software.
Auris Nasus Larynx. 2024 Dec;51(6):917-921. doi: 10.1016/j.anl.2024.08.007. Epub 2024 Sep 13.
8
Deposition of intranasal glucocorticoids--preliminary study.
Otolaryngol Pol. 2015;69(6):30-8. doi: 10.5604/00306657.1184545.
9
Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations.
J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):118-131. doi: 10.1089/jamp.2016.1295. Epub 2016 Dec 15.
10
Drug delivery in the nasal cavity after functional endoscopic sinus surgery: a computational fluid dynamics study.
J Laryngol Otol. 2012 May;126(5):487-94. doi: 10.1017/S0022215112000205. Epub 2012 Mar 14.

本文引用的文献

1
A large-volume low-pressure nasal irrigation delivers drug into the nasal cavity? An in vivo study.
Drug Deliv Transl Res. 2024 May;14(5):1232-1238. doi: 10.1007/s13346-023-01455-z. Epub 2023 Oct 26.
2
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery.
Signal Transduct Target Ther. 2022 Aug 30;7(1):301. doi: 10.1038/s41392-022-01135-3.
3
New intranasal and injectable gene therapy for healthy life extension.
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2121499119. doi: 10.1073/pnas.2121499119. Epub 2022 May 10.
4
Nasal delivery of thermostable and broadly neutralizing antibodies protects mice against SARS-CoV-2 infection.
Signal Transduct Target Ther. 2022 Feb 21;7(1):55. doi: 10.1038/s41392-022-00911-5.
7
Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis.
Pharmaceutics. 2021 Feb 10;13(2):246. doi: 10.3390/pharmaceutics13020246.
8
Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Drug Deliv Transl Res. 2022 Apr;12(4):735-757. doi: 10.1007/s13346-020-00891-5. Epub 2021 Jan 25.
9
Progressive 3D Printing Technology and Its Application in Medical Materials.
Front Pharmacol. 2020 Mar 20;11:122. doi: 10.3389/fphar.2020.00122. eCollection 2020.
10
Quantification of airflow in the sinuses following functional endoscopic sinus surgery.
Rhinology. 2020 Jun 1;58(3):257-265. doi: 10.4193/Rhin19.387.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验